Trade receivables increased 34.6%
Trade receivables changed +34.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables changed +34.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +208.6% from the comparable as-filed period.
Cash & equivalents changed -75.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current assets changed -60.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +46.0% from the comparable as-filed period.
Operating cash flow changed +41.9% from the comparable as-filed period.
Operating margin changed +959 basis points from the comparable as-filed period.
Total assets changed -29.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +576 basis points from the comparable as-filed period.
Net income changed +120.8% from the comparable as-filed period.
Working capital changed +115.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Current liabilities changed -61.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +23.9% from the comparable as-filed period.
Revenue changed +11.9% from the comparable as-filed period.
SBC / revenue changed -268 basis points from the comparable as-filed period.
Operating cash-flow margin changed +605 basis points from the comparable as-filed period.
Free-cash-flow margin changed +648 basis points from the comparable as-filed period.
Receivables / revenue changed +701 basis points from the comparable as-filed period.
Capital expenditure changed -24.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed -35.7% from the comparable as-filed period.
Working capital / assets changed +208 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +6.2% from the comparable as-filed period.
Stock-based compensation changed -14.1% from the comparable as-filed period.
Capex / revenue changed -43 basis points from the comparable as-filed period.
R&D / revenue changed -98 basis points from the comparable as-filed period.
Shares outstanding changed -1.2% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Cost of revenue changed -2.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed +4.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cash & equivalents changed -75.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -62.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -30.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +198.2% from the comparable as-filed period.
Operating margin changed +831 basis points from the comparable as-filed period.
Gross margin changed +566 basis points from the comparable as-filed period.
Net income changed +153.8% from the comparable as-filed period.
Free-cash-flow proxy changed +24.5% from the comparable as-filed period.
Working capital changed +80.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed -64.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash flow changed +24.7% from the comparable as-filed period.
Working capital / assets changed +375 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross profit changed +24.5% from the comparable as-filed period.
Revenue changed +12.6% from the comparable as-filed period.
Capital expenditure changed +30.1% from the comparable as-filed period.
Operating cash-flow margin changed +267 basis points from the comparable as-filed period.
SBC / revenue changed -218 basis points from the comparable as-filed period.
Free-cash-flow margin changed +257 basis points from the comparable as-filed period.
Operating cash flow / net income changed -50.9% from the comparable as-filed period.
Research & development changed +11.4% from the comparable as-filed period.
Trade receivables changed +16.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed -0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
Current ratio changed +4.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +117 basis points from the comparable as-filed period.
Capex / revenue changed +10 basis points from the comparable as-filed period.
Stock-based compensation changed -8.6% from the comparable as-filed period.
R&D / revenue changed -21 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.